Search

everythinglearnresearchcommunity

for

Search:↓

Older people tend to have higher biotin levels, which are weakly linked to certain blood components and negatively linked to triglycerides; biotin should be checked in patients with high triglycerides or medication-related skin issues, and only supplemented if deficient. Vitamin D and folate deficiencies are linked to specific skin conditions.

Most women with Polycystic Ovary Syndrome (PCOS) have skin issues like excessive hair, acne, or hair loss. Hormone imbalances are common, and age, certain hormones, and hormone ratios can predict acne. Obesity, infertility, and high cholesterol are also common in these women.

Hair loss in adults is linked to heart disease risk factors like unhealthy blood fats, lack of exercise, and alcohol use. It's also slightly more common in people with metabolic syndrome. As people age, hair loss gets worse. In men, severe hair loss is tied to high blood pressure and a larger waist. In women, it's tied to higher body weight. People with hair loss should be checked for unhealthy blood fats and advised to avoid alcohol and inactivity.

Patients with certain skin symptoms and high ANA titers should be monitored for potential systemic lupus.

The TRPV3 gene mutation affects hair growth by keeping mice in the growth phase longer, which could help treat hair loss.

New treatments for severe hair loss often fail, but some patients see hair regrowth with specific therapies, and treatment should be tailored to the individual's situation.

Many women with PCOS have undiagnosed health issues and show different symptoms based on the clinic they visit.

Insulin resistance is linked to high male hormone levels in women, often seen in those with PCOS.

Low-level laser therapy significantly increases hair density in adults with hair loss, with low-frequency treatment being more effective.

A two-step method was created in 2015 to make more cells that help with hair growth, but they need to be combined with other cells for 4 days to actually form new hair.

Immunomodulatory therapies are effective for treating cutaneous lymphoma, particularly in early stages.

Postmenopausal women with hyperandrogenism didn't have better metabolic health even after their testosterone levels became normal.

Adding estrogen increased bone mass in a transsexual man undergoing hormone therapy.

Blood tests can detect ovarian Leydig cell tumors when scans don't, and surgery can confirm and treat these tumors.

Dermatologists should use hair relaxers carefully to avoid hair and scalp damage, following specific guidelines for application and maintenance.

A woman's diabetes improved after removing ovarian tumors that caused high testosterone levels.

Macrophage activation syndrome can be a deadly first sign of systemic lupus erythematosus.

Proteomics combined with other technologies can lead to a better understanding of skin diseases.

The document concludes that early and accurate diagnosis of hair loss on the top of the scalp in Black men is important to distinguish CCCA from other types of hair loss.

Early balding, premature graying, and hair thinning can predict heart disease in young Asian males.

A postmenopausal woman's high testosterone levels and symptoms improved after removing a tumor from her ovary.

The lncRNA LOXL1-AS1 may help diagnose and treat androgenic alopecia.

PCOS is a major cause of infertility in women of childbearing age.

People with more than 11 skin tags, especially on the thigh, neck, or armpit, may have a higher chance of metabolic syndrome.

Non-invasive imaging helped diagnose a woman's severe hormone imbalance and diabetes, and medication successfully treated her condition.

PCOS affects many women and requires early detection and symptom management.

Store Tectona grandis leaf extracts in slightly acidic, light-protected conditions for best stability.

The patient with autoimmune hypothyroidism improved after treatment for thyroid and associated conditions.

Diagnosing sex development disorders requires combining medical history, physical exams, imaging, lab tests, and genetic data.

The study developed a 3D model that closely imitates remaining ovarian cancer after treatment and identified a potential drug targeting resistant cancer cells.